mRNA-1273.214
- Generic Name
- mRNA-1273.214
Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 68
- Registration Number
- NCT05584202
- Locations
- 🇺🇸
South Texas Clinical Research - Corpus Christi, Corpus Christi, Texas, United States
🇺🇸Cedar Health Research - Dedicated Research Facility, Dallas, Texas, United States
🇺🇸Eclipse Clinical Research, Tucson, Arizona, United States
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
- Conditions
- SARS-CoV-2
- Interventions
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 1860
- Registration Number
- NCT05436834
- Locations
- 🇦🇷
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Ciudad Autónoma De BuenosAires, Argentina
🇦🇷AES - AS - Glenny Corp. S.A. Buenos Aires, Caba, Ciudad Autónoma De Buenos Aires, Argentina
🇦🇷AES - AS - Clinica Mayo de Urgencias, San Miguel de Tucumán, Tucumán, Argentina
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
- Conditions
- Respiratory Syncytial Virus
- Interventions
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 3317
- Registration Number
- NCT05330975
- Locations
- 🇺🇸
Floridian Clinical Research - ClinEdge - PPDS, Miami Lakes, Florida, United States
🇺🇸Suncoast Research Associates LLC - ERN - PPDS, Miami, Florida, United States
🇺🇸Santa Rosa Medical Centers of Nevada - CCT Research, Las Vegas, Nevada, United States
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
- Conditions
- SARS-CoV-2
- Interventions
- First Posted Date
- 2021-06-15
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 5161
- Registration Number
- NCT04927065
- Locations
- 🇺🇸
Research Centers of America, Hollywood, Florida, United States
🇺🇸Jacksonville Center For Clinical Research, Jacksonville, Florida, United States
🇺🇸Meridian Clinical Research (Iowa), Sioux City, Iowa, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.